天億馬(301178.SZ):擬新設數字產業全資子公司 註冊資本1000萬元
格隆匯2月2日丨天億馬(301178.SZ)公佈,公司於2023年2月1日召開公司第三屆董事會第九次會議,審議通過了《關於對外投資設立全資子公司的議案》。公司計劃以自有資金不超過人民幣1000萬元進行對外投資,設立全資子公司廣東天億馬數字產業有限公司(暫定名,以當地市場監督管理局核准登記結果為準),註冊地為廣東省汕頭市金平區,註冊資本為人民幣1000萬元。
公司表示,此次對外投資是基於公司經營發展的需要,投資設立的全資子公司將圍繞公司主營業務開展相關經營活動,有助於公司進一步整合優化資源,完善公司在數字產業的業務發展和佈局,有利於公司增強盈利能力,提高綜合競爭力,實現長期戰略目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.